Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.

Journal of controlled release : official journal of the Controlled Release Society·2013
Same author

Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes.

Diabetes, obesity & metabolism·2013
Same author

Effects of parental history of hypertension and urbanization on blood pressure in Zimbabweans.

International journal of behavioral medicine·2005
Same author

Altered cardiovascular/pain regulatory relationships in chronic pain.

International journal of behavioral medicine·2005
Same author

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2005
Same author

Plasma glucose responses in recreational divers with insulin-requiring diabetes.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2004
Same journal

Table of Contents.

Psychosomatic medicine·2025
Same journal

All Issue Ads.

Psychosomatic medicine·2024
Same journal

Cover.

Psychosomatic medicine·2024
Same journal

Author and Subject Index.

Psychosomatic medicine·2024
Same journal

VOLUME CONTENTS AND INDEX.

Psychosomatic medicine·2024
Same journal

Associations Between Sexual Orientation Dimensions and Cardiometabolic Diseases: Data From the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III).

Psychosomatic medicine·2024
See all related articles

Related Experiment Video

Updated: Jul 1, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Classically conditioned hyperglycemia in the obese mouse.

R S Surwit, J A McCubbin, E G Livingston

    Psychosomatic Medicine
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Obese diabetic mice can develop stress-induced hyperglycemia through classical conditioning. This study shows obese mice, but not lean mice, learned to associate a metronome with stress, leading to conditioned hyperglycemia.

    More Related Videos

    Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
    08:13

    Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

    Published on: January 7, 2018

    Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
    10:28

    Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

    Published on: May 24, 2018

    Related Experiment Videos

    Last Updated: Jul 1, 2026

    Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
    11:10

    Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

    Published on: November 16, 2011

    Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
    08:13

    Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

    Published on: January 7, 2018

    Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
    10:28

    Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

    Published on: May 24, 2018

    Area of Science:

    • Endocrinology
    • Animal Models
    • Behavioral Science

    Background:

    • The obese (C57BL/6J ob/ob) mouse is a standard model for non-insulin-dependent diabetes mellitus.
    • This model requires environmental stress to consistently exhibit hyperglycemia.
    • Stress-induced hyperglycemia is a known physiological response.

    Purpose of the Study:

    • To investigate the potential for classical conditioning to induce hyperglycemia in obese mice.
    • To determine if obese mice exhibit conditioned stress responses differently than lean mice.

    Main Methods:

    • Obese diabetic and lean control mice were exposed to shaking stress.
    • Classical conditioning was induced by pairing a metronome with shaking stress.
    • Control groups received non-contingent or no stress exposure.
    • Blood glucose levels were measured after exposure to the metronome alone.

    Main Results:

    • All animals showed hyperglycemia in response to direct shaking stress.
    • Obese mice demonstrated classical conditioning, developing hyperglycemia when exposed to the metronome alone.
    • Lean mice did not show conditioned hyperglycemia.

    Conclusions:

    • Classical conditioning can induce hyperglycemia in the obese mouse model.
    • Obese mice exhibit a greater capacity for conditioned stress hyperglycemia compared to lean mice.
    • This finding has implications for understanding diabetes pathophysiology and stress responses.